MRK

Merck & Co

D
MRK
USD
-0.84
(-0.6376%)
Market Closed
228,588.00
Volume
8.615
EPS
2.29
Div Yield
145.444
P/E
331,544,345,586.30
Market Cap
Today
-0.6376%
1 Week
0.484%
1 Month
4.678%
6 Months
28.359%
12 Months
12.767%
Year To Date
20.064%
All Time
120.000%
Signals
avatar
sara abdelazim
8 months ago
sell
MRK
MRK@109.270
25.08.2023 14:16
Profit
16.50
TP1: 102.190
SL: 119.771
Close Price
108.940
Closed At
2023-08-29 06:33
avatar
sara abdelazim
8 months ago
buy
MRK
MRK@109.650
22.08.2023 13:43
Profit
50.50
TP1: 116.025
TP2: 119.653
SL: 105.650
Close Price
110.660
Closed At
2023-08-23 15:12
More
News

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
PFE
PFE
0.115
(0.3991%)
USD
JNJ
JNJ
1.59
(1.0412%)
USD
GSK
GSK
-0.83
(-1.8158%)
USD
ABT
ABT
0.27
(0.2582%)
USD
LLY
LLY
-15.73
(-1.9975%)
USD
BMY
BMY
-0.44
(-0.9874%)
USD
AMGN
AMGN
-4.27
(-1.3383%)
USD
SNY
SNY
-0.18
(-0.3671%)
USD
AZN
AZN
0.06
(0.0779%)
USD

Title:
Merck & Co

Sector:
Healthcare
Industry:
Drug Manufacturers - General
Merck & Co. Inc. is an integrated healthcare company specializing in healthcare solutions through prescription medication, vaccines, biologic therapies, animal health, and consumer- care products. The company headquarters are in Rahway, New Jersey. The origins of the company stretch as far back as 1668, when it was founded by the Merck family in Germany. The American subsidiary of the German founding firm was established in 1891. Merck & Co. Inc. frequently features in the top 100 of the Fortune 500 list of biggest American firms by revenue.
Do you need help or have a question?
Contact Us